Featured News

Newsroom

Michael O'LoughlinAustralian software developer Alltraders is the fourth fast-growing company in South Australia, based on the company’s first appearance on the Fast Movers list of rapidly-growing SA businesses.

The accolade, announced Friday, comes just three years after its owners, Ben Horner and Michael O’Loughlin, began running it as a full-time business. Alltraders, which has 20 employees and a turnover of about $1.5 million, recorded year-on-year growth of more than 80 per cent.

Compiled annually by inBusiness magazine, the Fast Mover SA Company Index recognises 25 of the fastest-growing businesses based in SA.

Alltraders CIO Michael O’Loughlin said the Fast Mover Index inclusion was an important recognition of how far the company had come. “The result reflects the efforts of a concerted and sustained effort by a dedicated team who are focused on getting the best possible solutions for clients,” he said.

John ConvillAdelaide security specialist Vision Security Services is experiencing strong demand for its Internet Protocol-based video door monitoring system from Mobotix.

Vision Security managing director John Convill said the Mobotix IP Video Door Station was hitting the market very well overseas and producing strong domestic interest.

“Door stations with integrated cameras have been around for years, but they’re almost always based on analogue TV technology that is over 60 years old. Because of that, they can only deliver very low image quality, with limited two-way communication. They’re also expensive to install because they needs a complex cabling and power supply system.

“By contrast, the Mobotix T24 IP Video Door Station is based on the international VoIP/SIP video telephony standard. When the doorbell rings, a connection is established with an IP video phone or a standard computer via the network. This means that, from anywhere in the world, you can conduct video conversations with visitors at your door or open the door remotely.

Peter Simic

New Zealand has demonstrated the depth of its winemaking credentials by taking out half of the major honours at the 2011 Australasian Winestate awards announced last week at Adelaide's National Wine Centre.? ?

Biggest surprise was the ‘Wine Of The Year’ awarded to a New Zealand red from Craggy Range Winery, Hawkes Bay with its Le Sol Syrah 2009, grown in the Gimblett Gravels district.? ?This is the first time in 15 years of this regional judging and 33 years of Winestate Publishing that Australia has handed over its shiraz trophy crown to a syrah. Winestate publisher Peter Simic said that New Zealand syrah had been showing up in the top 10 wines of the competition for the past 15 years, knocking at the door of the traditional stronghold of shiraz in Australia.? ?Rutherglen Double Awards for Morris

In a fitting Australian acknowledgement of the Morris family’s commitment over generations, the dual title of Australian Winemaker of the Year and Wine Company of the Year went to Morris of Rutherglen and David Morris.

“Morris has been a regular winner of the fortified section during each year of this competition, often winning four, or all five category, placings (again this year). The wines have an amazing track record of producing world class wines made by the current winemaker, David Morris, back to his father, the legendary Mick Morris’ involvement,” said Winestate editor, Peter Simic.

Australian biotech company CPR Pharma Services is now winning more than half of its business from customers based in the US.

The Adelaide-based business offers specialised services supporting drug development for the pharmaceutical and biotechnology industry internationally.
With more than 55 per cent of its clients in North America, CPR is active in two major areas: Site independent services for early phase clinical studies; and GLP bio-analytical services for clinical, pre-clinical and discovery studies.

During the past decade, CPR, which employs about 40 people, has continually grown and developed through the acquisition of key staff and major infrastructure additions. The company boasts an 85 per cent customer retention rate.

CPR’s core clients consist of global pharmaceutical and biotechnology companies, conducting at least some of their drug development program in the Australasian region. As well as expert and experienced staff with a strong client focus, CPR offers access to leading academic staff as consultants, state-of-the-art instrumentation (multiple LC/MS/MS capability) and commitment to pharmaceutical standards such as ICH GCP, GLP and ISO.